ATLAS VENTURE FUND V. L.P.

Company

ALNYLAM PHARMACEUTICALS, INC.

Filed

February 9, 2005

Accession Number

0000950135-05-000534

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →